I believe over the next several weeks and months w
Post# of 30029
In addition to all the LymPro and MANF stuff we're all anticipating, I wouldn't be surprised if we acquired a COMPANION TEST TO LYMPRO. Maybe we acquire another company with such a test? Gerald has said we are looking to acquire other assets. Docstock mentioned we might acquire another asset (company).
I think Jason Napodano will give us a new Target Price. I think other analysts will also initiate coverage with us. I think these analysts opinions of us as well as all the media attention bearing down on us will also influence the stock price.
In other words, good luck trying to time the stock! It's going to be all over the place! But by November it will be somewhere between .40 cents and $1.00.